Your browser doesn't support javascript.
loading
Clinical Implications of Complex Pharmacokinetics for Daratumumab Dose Regimen in Patients With Relapsed/Refractory Multiple Myeloma.
Xu, X S; Yan, X; Puchalski, T; Lonial, S; Lokhorst, H M; Voorhees, P M; Plesner, T; Liu, K; Khan, I; Jansson, R; Ahmadi, T; Ruixo, Jj Perez; Zhou, H; Clemens, P L.
Afiliação
  • Xu XS; Janssen Research & Development, LLC, Raritan, New Jersey, USA.
  • Yan X; Janssen Research & Development, LLC, Raritan, New Jersey, USA.
  • Puchalski T; Janssen Research & Development, LLC, Spring House, Pennsylvania, USA.
  • Lonial S; Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University, Atlanta, Georgia, USA.
  • Lokhorst HM; VU University Medical Center, Amsterdam, The Netherlands.
  • Voorhees PM; Division of Hematology/Oncology, Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
  • Plesner T; Vejle Hospital and University of Southern Denmark, Vejle, Denmark.
  • Liu K; Janssen Research & Development, LLC, Raritan, New Jersey, USA.
  • Khan I; Janssen Research & Development, LLC, Raritan, New Jersey, USA.
  • Jansson R; Janssen Research & Development, LLC, Spring House, Pennsylvania, USA.
  • Ahmadi T; Janssen Research & Development, LLC, Spring House, Pennsylvania, USA.
  • Ruixo JP; Janssen Research & Development, Beerse, Belgium.
  • Zhou H; Janssen Research & Development, LLC, Spring House, Pennsylvania, USA.
  • Clemens PL; Janssen Research & Development, LLC, Spring House, Pennsylvania, USA.
Clin Pharmacol Ther ; 101(6): 721-724, 2017 Jun.
Article em En | MEDLINE | ID: mdl-27859027

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Cálculos da Dosagem de Medicamento / Anticorpos Monoclonais / Mieloma Múltiplo / Antineoplásicos Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Humans Idioma: En Revista: Clin Pharmacol Ther Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Cálculos da Dosagem de Medicamento / Anticorpos Monoclonais / Mieloma Múltiplo / Antineoplásicos Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Humans Idioma: En Revista: Clin Pharmacol Ther Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Estados Unidos